Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace

The new 7600 square feet custom-built, state-of-the-art facility hosts Denovo's biomarker discovery platform, US clinical team and serves as Denovo's US headquarters. Source: BioSpace

BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.…

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace

The annual Hotbed Maps have guided professionals in their career paths all across the country and abroad. Source: BioSpace

The funds will be used to expand its growing pipeline and progress several early stage molecules towards the clinic. Source: BioSpace

Sangamo and Pfizer will use the company's ZFP-TFs to develop the treatments that are linked to mutations of the C9ORF72 gene, which can cause both ALS and FTLD. Source: BioSpace

The cash will support expansion in translational informatics, clinical trials, and broadened use of biomedical data. Source: BioSpace

A look at two biopharma companies that fall into this category that investors should check out. Source: BioSpace

Centrexion closed on a Series D financing worth $67M to develop its knee osteoarthritis drug in Phase III. Source: BioSpace